ArticleFrontiers in oncology2024

Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations.

Jiaqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.